Resilience Mobile App for Teens and Young Adults With Cancer

Launched by SEATTLE CHILDREN'S HOSPITAL · Apr 21, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a mobile app designed to help teens and young adults who have recently been diagnosed with cancer. The app, called the Resilience Mobile App, is based on a program that aims to help young people manage stress and improve their overall quality of life and mental health. Researchers want to see if the app is easy to use and if it can really make a difference for its users.

To participate in this study, individuals need to be between the ages of 12 and 25 and must have been diagnosed with a new type of cancer within the last year. They should also be receiving treatment, such as chemotherapy or radiation therapy, at Seattle Children's Hospital. Participants will be asked to use the app and share their experiences through interviews and surveys. This is a great opportunity for young people to engage in a supportive tool that may help them during their cancer journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 12-25 years
• • Diagnosis of new malignancy within 12 months of enrollment treated with chemotherapy and/or radiation therapy at Seattle Children's Hospital (SCH)
• • Patient able to speak/read/write English or Spanish language
• • Cognitively able to participate in mHealth psychosocial intervention and interactive interviews
• Exclusion Criteria:
• • Patient refusal to participate (any age), or parental refusal to participate for patients less than 18 years of age
• • Patients with diagnosis of malignancy \>12 months
• • Patients with relapsed, recurrent, or refractory disease
• • Patient without chemotherapy and/or radiation therapy as part of cancer treatment (e.g., surgical resection only patients are not-eligible)
• • Cognitively or physically unable to participate in mHealth psychosocial intervention and surveys